Cargando…
The Epigenetic Enzyme KMT2A/MLL1 Is a Driver of Coronavirus-associated Coagulopathy
| Autores principales: | , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187508/ http://dx.doi.org/10.1016/j.jvssci.2022.05.005 |
| _version_ | 1784725185210875904 |
|---|---|
| author | Sharma, Sriganesh B. Melvin, William J. Audu, Christopher O. Kanthi, Yogendra Knight, Jason S. Rhoads, Nicole Adili, Reheman Holinstat, Michael A. Moore, Bethany B. Henke, Peter K. Wakefield, Thomas W. Gallagher, Katherine A. Obi, Andrea T. |
| author_facet | Sharma, Sriganesh B. Melvin, William J. Audu, Christopher O. Kanthi, Yogendra Knight, Jason S. Rhoads, Nicole Adili, Reheman Holinstat, Michael A. Moore, Bethany B. Henke, Peter K. Wakefield, Thomas W. Gallagher, Katherine A. Obi, Andrea T. |
| author_sort | Sharma, Sriganesh B. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9187508 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91875082022-06-13 The Epigenetic Enzyme KMT2A/MLL1 Is a Driver of Coronavirus-associated Coagulopathy Sharma, Sriganesh B. Melvin, William J. Audu, Christopher O. Kanthi, Yogendra Knight, Jason S. Rhoads, Nicole Adili, Reheman Holinstat, Michael A. Moore, Bethany B. Henke, Peter K. Wakefield, Thomas W. Gallagher, Katherine A. Obi, Andrea T. JVS Vasc Sci Article Published by Elsevier Inc. 2022 2022-06-11 /pmc/articles/PMC9187508/ http://dx.doi.org/10.1016/j.jvssci.2022.05.005 Text en Copyright © 2022 Published by Elsevier Inc. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Article Sharma, Sriganesh B. Melvin, William J. Audu, Christopher O. Kanthi, Yogendra Knight, Jason S. Rhoads, Nicole Adili, Reheman Holinstat, Michael A. Moore, Bethany B. Henke, Peter K. Wakefield, Thomas W. Gallagher, Katherine A. Obi, Andrea T. The Epigenetic Enzyme KMT2A/MLL1 Is a Driver of Coronavirus-associated Coagulopathy |
| title | The Epigenetic Enzyme KMT2A/MLL1 Is a Driver of Coronavirus-associated Coagulopathy |
| title_full | The Epigenetic Enzyme KMT2A/MLL1 Is a Driver of Coronavirus-associated Coagulopathy |
| title_fullStr | The Epigenetic Enzyme KMT2A/MLL1 Is a Driver of Coronavirus-associated Coagulopathy |
| title_full_unstemmed | The Epigenetic Enzyme KMT2A/MLL1 Is a Driver of Coronavirus-associated Coagulopathy |
| title_short | The Epigenetic Enzyme KMT2A/MLL1 Is a Driver of Coronavirus-associated Coagulopathy |
| title_sort | epigenetic enzyme kmt2a/mll1 is a driver of coronavirus-associated coagulopathy |
| topic | Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9187508/ http://dx.doi.org/10.1016/j.jvssci.2022.05.005 |
| work_keys_str_mv | AT sharmasriganeshb theepigeneticenzymekmt2amll1isadriverofcoronavirusassociatedcoagulopathy AT melvinwilliamj theepigeneticenzymekmt2amll1isadriverofcoronavirusassociatedcoagulopathy AT auduchristophero theepigeneticenzymekmt2amll1isadriverofcoronavirusassociatedcoagulopathy AT kanthiyogendra theepigeneticenzymekmt2amll1isadriverofcoronavirusassociatedcoagulopathy AT knightjasons theepigeneticenzymekmt2amll1isadriverofcoronavirusassociatedcoagulopathy AT rhoadsnicole theepigeneticenzymekmt2amll1isadriverofcoronavirusassociatedcoagulopathy AT adilireheman theepigeneticenzymekmt2amll1isadriverofcoronavirusassociatedcoagulopathy AT holinstatmichaela theepigeneticenzymekmt2amll1isadriverofcoronavirusassociatedcoagulopathy AT moorebethanyb theepigeneticenzymekmt2amll1isadriverofcoronavirusassociatedcoagulopathy AT henkepeterk theepigeneticenzymekmt2amll1isadriverofcoronavirusassociatedcoagulopathy AT wakefieldthomasw theepigeneticenzymekmt2amll1isadriverofcoronavirusassociatedcoagulopathy AT gallagherkatherinea theepigeneticenzymekmt2amll1isadriverofcoronavirusassociatedcoagulopathy AT obiandreat theepigeneticenzymekmt2amll1isadriverofcoronavirusassociatedcoagulopathy AT sharmasriganeshb epigeneticenzymekmt2amll1isadriverofcoronavirusassociatedcoagulopathy AT melvinwilliamj epigeneticenzymekmt2amll1isadriverofcoronavirusassociatedcoagulopathy AT auduchristophero epigeneticenzymekmt2amll1isadriverofcoronavirusassociatedcoagulopathy AT kanthiyogendra epigeneticenzymekmt2amll1isadriverofcoronavirusassociatedcoagulopathy AT knightjasons epigeneticenzymekmt2amll1isadriverofcoronavirusassociatedcoagulopathy AT rhoadsnicole epigeneticenzymekmt2amll1isadriverofcoronavirusassociatedcoagulopathy AT adilireheman epigeneticenzymekmt2amll1isadriverofcoronavirusassociatedcoagulopathy AT holinstatmichaela epigeneticenzymekmt2amll1isadriverofcoronavirusassociatedcoagulopathy AT moorebethanyb epigeneticenzymekmt2amll1isadriverofcoronavirusassociatedcoagulopathy AT henkepeterk epigeneticenzymekmt2amll1isadriverofcoronavirusassociatedcoagulopathy AT wakefieldthomasw epigeneticenzymekmt2amll1isadriverofcoronavirusassociatedcoagulopathy AT gallagherkatherinea epigeneticenzymekmt2amll1isadriverofcoronavirusassociatedcoagulopathy AT obiandreat epigeneticenzymekmt2amll1isadriverofcoronavirusassociatedcoagulopathy |